Buscarini, E., Botella, L. M., Geisthoff, U., Kjeldsen, A. D., Mager, H. J., Pagella, F., . . . Shovlin, C. L. (2019). Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. Orphanet J Rare Dis.
Παραπομπή Chicago StyleBuscarini, Elisabetta, et al. "Safety of Thalidomide and Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia." Orphanet J Rare Dis 2019.
Παραπομπή MLABuscarini, Elisabetta, et al. "Safety of Thalidomide and Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia." Orphanet J Rare Dis 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.